CardioSignal develops digital technologies and software-as-medical-devices to provide early detection of heart diseases
CardioSignal has raised €9.2M across 1 funding round from 3 investors, most recently a Series A round in Jan 2024. Based in Turku, Finland; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-24 | Series A | €9.2M |
| DigiTx Partners,Maki.vc,Sandwater |
| View deal → |
